OLIVIA ZACZYK: Open Payments
NPI 1477254639 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,861 in 99 payments from 17 companies in 2025. Trend: 2023 $887 · 2024 $1,254 · 2025 $1,861
Food & beverage: $1,686Education: $175
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $298 |
| ABBVIE INC. | 27 | $286 |
| Incyte Corporation | 7 | $191 |
| UCB, Inc. | 8 | $191 |
| Lilly USA, LLC | 15 | $154 |
| Janssen Biotech, Inc. | 4 | $143 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $87 |
| GENZYME CORPORATION | 5 | $83 |
| Amgen Inc. | 2 | $58 |
Products named: SKYRIZI, OPZELURA, Bimzelx, TREMFYA, COSENTYX, DUPIXENT, EBGLYSS, SPEVIGO.
Industry payments across IN — which companies pay providers there.
